© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 13, 1110A-1112,
July 7, 1999
© 1999 Oxford University Press
NEWS |
Awards, Appointments, Announcements
During the recent IX International Congress on Anti-Cancer Treatment, held in Paris, three individuals received awards:Gabriel N. Hortobagyi, M.D., received the Vermeille Medal of Paris for his contributions to breast cancer research. Hortobagyi is professor and chairman of the Department of Breast Medical Oncology at the University of Texas M. D. Anderson Cancer Center, Houston.
Waun Ki Hong, M.D., received the Claude Jacquillat Award for Achievement in Clinical Oncology for his contributions to development of chemoprevention strategies. Hong is professor and chairman of the Department of Thoracic/Head and Neck Medical Oncology at M. D. Anderson.
Carlo M. Croce, M.D., received the Raymond Bourgine Award for his achievements in cancer research. Croce is editor-in-chief of Cancer Research and director of the Kimmel Cancer Center at Thomas Jefferson University, Philadelphia.
UW Honors Weiss
The University of Washington, Seattle, named Noel S. Weiss, M.D., Dr.P.H., as its 1999 Distinguished Graduate Mentor. The university said that this is the first time it has formally recognized outstanding mentoring of its graduate students.
Weiss is an epidemiologist in the Public Health Sciences Division of the Fred Hutchinson Cancer Research Center and professor of epidemiology in the university's School of Public Health and Community Medicine.
ONS Presents Major Awards
The Oncology Nursing Society, Pittsburgh, presented its major awards recently during its annual congress in Atlanta.
Carol B. Curtiss received the Distinguished Service Award, sponsored by ONS and Roche Laboratories, Inc., for outstanding contributions to ONS. She is a clinical specialist consultant in Greenfield, Mass. Marcia L. M. Grant, D.NSc., received the Distinguished Researcher Award, sponsored by ONS and Bristol-Myers Squibb Oncology Division. She is a research scientist at City of Hope National Medical Center, Duarte, Calif.
Shizko Kiba, director of the Institute of Hospice Care in Toshima-Ku, Tokyo, received the International Award for Contributions to Cancer Care. Janice Phillips, Ph.D., program director at the National Institute of Nursing Research, Bethesda, Md., presented the Mara Mogenson Flaherty Memorial Lecture.
Freeman Heads Hospital
North General Hospital, New York, announced that its directors selected Harold P. Freeman, M.D., as its new president and chief executive officer, effective Aug. 1.
Freeman has been North General's director of surgery, and was director of surgery at Harlem Hospital Center. He will continue as medical director of the Breast Examination Center of Harlem and as a member of the clinical faculty of Columbia University. He also is chairman of the President's Cancer Panel.
Giovino Joins RPCI Staff
The Roswell Park Cancer Institute, Buffalo, N.Y. announced that Gary Giovino, Ph.D., has joined its faculty in the Department of Cancer Prevention, Epidemiology and Biostatistics. He has been chief of the Epidemiology Branch of the Office on Smoking and Health, Centers for Disease Control and Prevention, Atlanta.
|
Giovino will lead a Robert Wood Johnson Foundation-funded project to track tobacco control activities in the United States, identifying policies that are effective in reducing adolescent tobacco use.
Schilsky Named Associate Dean
After 8 years as director of the University of Chicago Cancer Research Center, Richard L. Schilsky, M.D., left that post July 1 to become associate dean for clinical research, a new position in the university's Division of Biological Sciences. He was succeeded at the cancer center by Nicholas J. Vogelzang, M.D., who has been on the university faculty since 1982.
|
|
The university also announced that last month Schilsky became chair of the Food and Drug Administration's Oncologic Advisory Committee. He will remain chairman of the cooperative group known as Cancer and Leukemia Group B.
In addition to his appointment as cancer center director, Vogelzang was named the first Fred C. Buffett Professor of Medicine.
Novello Named NY Health Chief
New York Governor George E. Pataki last month nominated former U.S. Surgeon General Antonia C. Novello, M.D., as New York State's health commissioner. Her appointment needs confirmation by the State Senate.
Most recently, Novello has been a visiting professor of health policy and management at the Johns Hopkins School of Hygiene and Public Health, Baltimore. Earlier, she was deputy director of the National Institute of Child Health and Human Development.
ONS Elects 1999-2000 Board
The Oncology Nursing Society, Pittsburgh, elected Roberta A. Strohl, of the University of Maryland faculty, as president for 1999-2000. New president-elect is Paula Trahan Rieger, of the University of Texas M. D. Anderson Cancer Center, Houston.
New secretary is Marcia A. Satryan, Altoona, Pa. New treasurer is Luana Lamkin, Denver. Newly elected directors are Barbara Rogers, Fox Chase Cancer Center, Philadelphia; and Patty Jassak, Chicago.
NeoRx Elects Two
NeoRx Corp., Seattle, announced that it elected Robert Caspari, M.D., as vice president of medical and regulatory affairs, and Karen Auditore-Hargreaves, Ph.D., as vice president of research and development. Caspari had been with Baxter International, Inc., and Auditore-Hargreaves had been at CellPro, Inc.
NeoRx said in its announcement that the company is developing products to "provide improved, cost-effective treatments for patients with cancer and inflammatory diseases."
ONS Gains Corporate Support
The Oncology Nursing Society announced that its fund-raising campaign to create a national Center for Leadership, Information, and Research has raised nearly $10 million.
Major corporate gifts were pledged by Amgen ($2.25 million), Bristol-Myers Squibb ($1.6 million), Ortho Biotech ($1 million), and Schering Oncology/Biotech ($1 million).
Clinical Trials Blueprint
The National Cancer Institute launched its new clinical trials system, changing the way NCI-sponsored large, multi-centered treatment trials are proposed, reviewed, and coordinated. A booklet about the new system, Clinical Trials: A Blueprint for the Future, is available free-of-charge from the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). Requests also may be e-mailed to Jana Johnston at johnstonj{at}occ.nci.
Lymphoma Fellowships
The Cure for Lymphoma Foundation, New York, is seeking candidates for its 2-year fellowship grant program that is designed to encourage careers in lymphoma translational and clinical research. Results of the research, which can be laboratory- or clinic-based, must be relevant to lymphoma treatment. Application deadline is Nov. 15.
The grants provide salary support ($45,000 the first year and $50,000 the second) and $5,000 each year for the research project. More information is available from the foundation at 212-213-9595. The fax number is 212-213-1987, and e-mail address is InfoCFL{at}cfl.org.
Major Gift to Penn
The University of Pennsylvania Cancer Center, Philadelphia, received a $4.5 million gift from the William H. Gates Foundation to support research on adoptive immunotherapy targeting non-Hodgkin's lymphoma.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||